Similarly, Chen et al. (33) demonstrated that HBOT combined with selegiline further reduced serum MDA levels and enhanced serum SOD levels, thereby improving motor functions and sleep quality in PD patients with sleep disorders. This evidence concerns the gene SOD1 and Parkinson disease.